← Leaderboards
Felicia C. Chow
University Of California, San Francisco
$4,973,965
Attributed
$5,671,699
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,671,699 · 6
By mechanism
R01$3,342,592 · 2
K23$1,000,260 · 1
R21$681,260 · 2
T32$647,587 · 1
Top collaborators
- Bruce Ovbiagele2 shared
- Vidya Mave1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Alka M Kanaya$23,487,726
- Margot B Kushel$15,430,352
- Gabriel Chamie$8,918,315
- Scarlett L Gomez$14,448,454
- Adam Wayne Carrico$20,345,043
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantFundingHiv InfectionsPathogenesisGeneral PopulationLinkPublic HealthCerebrovascular DisordersPreventCerebrumAntiretroviral TherapyPathway InteractionsCerebrovascularResearch PersonnelTrainingImmune ActivationInflammationMediatingFutureCardiovascular DiseasesNeurologyObservational StudyIschemic StrokeClinical Research
Grant awards (16)
Reimagining the IMAGINE-TBM trial: Using metagenomics and host transcriptomics to improve our ability to diagnose tuberculous meningitis and assess response to treatment in a randomized clinical trial$747,881
R01 · FY2025 · NS · contact PI
Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infection$646,517
R01 · FY2025 · NS · contact PI
ENLIGHTEN (ENgaging Leaders In Global and local HealTh Equity in Neurology)$415,251
T32 · FY2025 · NS
Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infection$634,138
R01 · FY2024 · NS · contact PI
ENLIGHTEN (ENgaging Leaders In Global and local HealTh Equity in Neurology)$232,336
T32 · FY2024 · NS
Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infection$650,356
R01 · FY2023 · NS · contact PI
Sex differences in the contribution of cerebrovascular injury and immune activation to neurocognitive impairment in HIV infection$663,700
R01 · FY2022 · NS · contact PI
Effects of the neural and inflammatory response to stress on cerebrovascular risk in HIV infection$200,052
K23 · FY2021 · NS · contact PI
Effects of the neural and inflammatory response to stress on cerebrovascular risk in HIV infection$200,052
K23 · FY2020 · NS · contact PI
Effects of the neural and inflammatory response to stress on cerebrovascular risk in HIV infection$200,052
K23 · FY2019 · NS · contact PI
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis$146,147
R21 · FY2019 · TW · contact PI
Effects of the neural and inflammatory response to stress on cerebrovascular risk in HIV infection$200,052
K23 · FY2018 · NS · contact PI
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis$176,179
R21 · FY2018 · TW · contact PI
Effects of the neural and inflammatory response to stress on cerebrovascular risk in HIV infection$200,052
K23 · FY2017 · NS · contact PI
Cerebrovascular mechanisms of HIV-associated cognitive impairment in China$168,373
R21 · FY2017 · TW · contact PI
Cerebrovascular mechanisms of HIV-associated cognitive impairment in China$190,561
R21 · FY2016 · TW · contact PI